cbdMD, Inc. (YCBD) Bundle
cbdMD, Inc. Reports $4.72 Million Revenue and Improved Operating Results
cbdMD, Inc. (NYSE American: YCBD) reported financial results on December 19, 2025, with revenue reaching approximately $4.72 million for the period. The figure exceeded the estimated $4.70 million, indicating steady growth for the CBD industry participant.
The company reported a loss from operations of $2.1 million, which represents a significant reduction from the $3.3 million loss recorded in fiscal 2024. Management attributed this improvement to disciplined cost management and continued investment in science and product quality across its portfolio, which includes Herbal Oasis THC seltzers, ATRx functional mushroom supplements, and Paw CBD.
To support working capital and strategic initiatives, cbdMD, Inc. completed a Series C Preferred Stock private placement totaling $2.25 million. After expenses, the company received net proceeds of approximately $2.1 million. The Series C shares carry a 10% annual dividend and include conversion options for investors.
The company financial position is characterized by the following metrics:
- A debt-to-equity ratio of 0.16, representing modest debt levels.
- A current ratio of 1.56, indicating the ability to cover short-term liabilities.
- Net proceeds of $2.1 million from recent private placement activities.
Further information regarding the company background and operations can be found in the YCBD-history-mission-ownership and YCBD-mission-vision reports. Analysis of the company fiscal stability is available via the YCBD-financial-health and YCBD-investor-profile resources.
cbdMD, Inc. (YCBD) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.